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Introduction
Among revascularization methods for critical lower limb ischemia 
(CLI), surgical bypass is regarded as the gold standard, with better 
anatomical and clinical durabilities.1-3) However, patients with CLI are 
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Background and Objectives: With recent advances in equipment and techniques, infrapopliteal angioplasty has shown results that are 
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males; mean age 66 years) with CLI (Rutherford category 4, 5 or 6). Freedom from reintervention, limb salvage, and overall survival were 
analyzed.  
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often aged and not optimal candidates for surgical bypass due to 
medical co-morbidities with increasing perioperative mortality rates 
and a poor autogeneous conduit.4)5) As an alternative method of re-
vascularization, infrapopliteal angioplasty is preferred by patients 
with visible stumps, good runoff of distal outflow vessels or high sur-
gical risk. However, it had been regarded as an inferior treatment op-
tion compared to surgical bypass due to bulky catheters, lack of low 
caliber wires and general lack of clinical experience which frequent-
ly resulted in periprocedural complications.4)6-8) Recently, newly de-
veloped devices and technical advances have widened the therapeu-
tic spectrum of angioplasty to more distal and complex lesions with 
lower complication rates.9)10) Also, it rarely compromises the option of 
future surgical procedures because it preserves the saphenous vein for 
lower extremity distal bypass surgery while at the same time it reduc-
es the cost and shortens the hospital stay.10)
In this study, we evaluated the feasibility and the efficacy of infr-
apopliteal angioplasty in terms of primary patency and limb salvage 
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as a primary choice of treatment in patients with CLI. Moreover, we 
evaluated predictors associated with poor primary patency and poor 
survival in these patients.
Subjects and Methods
Study subjects
Between April 2002 and May 2008, we retrospectively analyzed 118 
limbs of 101 patients with CLI (Rutherford-Becker grades11) 4, 5, or 6) 
who had been treated by infrapopliteal angioplasty. Demographic, lab-
oratory, technical, and clinical characteristics were retrospectively 
collected from their medical records. Blood samples were collected 
one day before or immediately before the index procedure.
 
Percutaneous transluminal angioplasty procedure
Vascular access for infrapopliteal angioplasty was gained via ipsi-
lateral or contralateral puncture of the common femoral artery. An 
antegrade approach was preferred when there were no combined 
lesions requiring proximal iliac or femoral intervention and in pa-
tients without obesity, due to better maneuverability of the catheters 
and better control of the wiring in case of total occlusion. After place-
ment of the 6 to 7 French sheath under local anesthesia, an intra-ar-
terial bolus of 5000 IU of heparin was given, and additional heparin 
was administered to maintain an activated clotting time between 250 
to 300 seconds, if procedure time was lengthened. Infrapopliteal le-
sions were passed with a 0.014” to 0.035” guide wire. If the initial trans-
luminal recanalization failed, total occlusions were recanalized through 
the subintimal dissection plane with reentrance into the true lumen 
using 0.035” hydrophilic guide wires (Terumo, Tokyo, Japan). After 
crossing the lesion, a 4 Fr to 5 Fr multipurpose catheter was advanced 
to the distal patent segment in exchange with a 0.014” wire. Percu-
taneous transluminal angioplasty (PTA) was then performed with ad-
equate sized balloons (2.25 to 4.0 mm) at 6-10 atmospheres. In case 
of elastic recoil or a flow limiting dissection after balloon dilatation, 
stents were implanted for bailout purposes. When proximal lesions ex-
isted, including ipsilateral iliac, femoral or popliteal artery lesions, con-
comitant procedures were performed.
Follow-up
Prior to intervention, patients were premedicated with aspirin (100 
mg, daily) and maintained on this dose indefinitely after PTA. Follow-
up included a clinical examination during the hospital stay and 1 
month after the intervention to document hemodynamic improve-
ment. Subsequent follow-up was considered when there was a ques-
tion of worsening clinical status. If necessary, repeat peripheral angi-
ography or a computed tomography angiogram was scheduled on 
their visit. The causes and date of death were examined by chart re-
view, telephone contact with family members, or checking with the 
national statistical office.
Angiographic findings and clinical outcomes
Technical success was defined as PTA resulting in less than 30% 
residual stenosis with sufficient antegrade flow; a suboptimal result 
was defined as sluggish flow and/or residual stenosis 30% to 50% 
after repeated dilatation. Primary clinical success was defined as an 
improvement of at least one clinical category in the Rutherford-Beck-
er classification.11) Primary patency was defined as persistent paten-
cy without any re-intervention including angioplasty, surgical proce-
dures performed on or at the margins of the treated lesion, or ampu-
tation. Limb salvage was defined as prevention of major amputation. 
Major amputation was defined as limb loss below or above the knee 
level, while minor amputation was defined as a transmetatarsal or 
more distal level amputation of the lower extremity.
Statistical analysis
We analyzed data using the Statistical Package for the Social Sci-
ences (SPSS) software (version 15.0; SPSS Inc., Chicago, IL, USA). Data 
are presented as the mean±standard deviation for continuous vari-
ables and as number (percentage) for categorical variables. Student’s 
t-test was used for comparison of continuous variables, and chi-
square analysis was used for comparison of categorical variables. 
Event-free survival curves were constructed by the Kaplan-Meier 
method. All significant univariate predictors of poor primary patency 
and poor survival were included in the multivariate logistic regres-
sion analyses. A p less than 0.05 was considered significant.
Results
Demographic characteristics of the study patients
Demographic characteristics of the patients are listed in Table 1. 
The mean age of the study population was 65.6±13.8 years, with 
79 (78%) men and 22 (22%) women. Many patients had significant 
co-morbidities including hypertension (68%), diabetes mellitus 
(69%), coronary artery disease (54%), chronic renal failure (41%), and 
a history of a cerebrovascular accident (11%). Also, six patients were 
smokers among eight patients who were diagnosed with Buerger’s 
disease (mean age 42 years).12) Fifty-two limbs were identified as 
Rutherford category 4 (44%), 20 limbs as Rutherford category 5 (17%), 
and 46 limbs as Rutherford category 6 (39%).
Laboratory data of the study patients
Laboratory data of the patients are listed in Table 1. The mean 
blood urea nitrogen level was 25.7±15.6 mg/dL, and the mean cre-
atinine level 2.62±2.90 mg/dL. The mean estimated glomerular filtra-
261Hyeon Min Ryu, et al.
http://dx.doi.org/10.4070/kcj.2012.42.4.259www.e-kcj.org
tion rate was 54.2±33.1 mL/min/1.73 m2.
Angiographic findings of the study patients
Angiographic findings of the study patients are shown in Table 2. 
A total of 161 lesions were treated in 118 limbs of 101 patients with 
CLI. Anterior tibial artery was the most commonly treated location 
(53%), and totally occluded arteries were observed in 60 limbs (51%). 
Concomitant procedures in the proximal lesion as ipsilateral iliac or 
superficial femoral artery were performed in 51 limbs (43%). Among 
them, a superficial femoral artery procedure was most commonly 
performed (36%). Antegrade access was done in 58 limbs (49%), and 
subintimal angioplasty was done in 11 limbs (9%). Initial technical 
success was achieved in 82 limbs (69.5%). On final angiography, a 
suboptimal result was obtained in 26 limbs (22%), which showed 
diffuse and heavily calcified lesions at initial presentation. There were 
10 technical failures due to 8 unsuccessful placements of guide 
wires, 1 heavy calcified lesion, and 1 arterial rupture. No major com-
plication requiring surgical intervention occurred after PTA. Minor 
procedural complications such as flow limiting dissection, rupture, 
and embolization occurred in 25 limbs (21%), which were treated by 
conservative treatment or stent implantation. In 10 cases of elastic re-
coil or flow limiting dissection, 11 stents were implanted for bailout 
purpose. Types of stents included 8 bare-metal coronary stents, 2 
drug-eluting coronary stents, and 1 balloon-expandable peripheral 
stent. Among 11 stents, 3 were implanted in the anterior tibial artery, 
5 in the posterior tibial artery, and 3 in the peroneal artery.
There were no significant differences in terms of technical success 
Table 1. Demographic and laboratory characteristics of the study population
Total number of patients 101
Demographic characteristics
   Age (years) 65.6±13.8
   Male gender (%) 79 (78)
   Body mass index (kg/m2) 22.9±3.5
   Comorbid disease (%)
      Hypertension 69 (68)
      Diabetes mellitus 70 (69)
      Cerebrovascular accident 11 (11)
      Coronary artery disease 54 (54)
      Chronic renal failure* 41 (41)
      Buerger’s disease 8 (8)
      Smoker 42 (42)
   Clinical category (%)
      Rutherford 4†‡ 52 (44)
      Rutherford 5†‡ 20 (17)
      Rutherford 6†‡ 46 (39)
Laboratory data
   White blood cell count/μL 8228±2818
   Hemoglobin (g/dL) 11.3±1.9
   Platelet count/μL 272860±80714
   Sodium level (mmol/L) 138.5±3.8
   Potassium level (mmol/L) 4.4±0.6
   Blood urea nitrogen level (mg/dL) 25.7±15.6
   Creatinine level (mg/dL) 2.62±2.90
   Estimated glomerular filtration rate (mL/min/1.73 m2) 54.2±33.1
Data are expressed as the mean value±SD or percentage of patients. *Se-
rum creatinine >1.5 mg/dL, †Among 118 limbs, ‡Rutherford classification 
can be found in reference 11
Table 2. Angiographic findings and clinical outcomes of the study population
Total limbs/lesions 118/161
Angiographic findings (%)
Left limb 63 (53)
Location
Anterior tibial artery 86 (73)
Posterior tibial artery 42 (36)
Peroneal artery 30 (25)
Total occlusion 60 (51)
Combined procedure 51 (43)
Iliac artery   7 (6)
Femoral artery 42 (36)
Popliteal artery 16 (14)
Antegrade approach 58 (49)
Subintimal approach 11 (9)
Stent implantation 10 (9)
Technical success 82 (70)
Suboptimal results 26 (22)
Complication 25 (21)
Dissection 25 (21)
Rupture   6 (5)
Embolism   1 (1)
Clinical outcomes (%)
Primary clinical success 98 (83)
Re-PTA   7 (6)
Surgery 44 (37)
Major amputation   6 (5)
Minor amputation 41 (35)
One year primary patency* 58 (71)
Two year primary patency* 58 (71)
One year limb salvage* 80 (98)
Two year limb salvage* 80 (98)
One year survival† 87 (86)
Two year survival† 76 (75)
Data are expressed as percentage of limbs. *Among 82 limbs with initial 
technical success, †Among 101 patients. PTA: percutaneous transluminal an-
gioplasty
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(82% vs. 74%, p=0.726) irrespective of the presence or absence of 
subintimal angioplasty.
Clinical outcomes of the study patients
Clinical outcomes of the patients are shown in Table 2. Primary 
clinical success was obtained in 98 limbs (83.1%); 18 limbs showed 
persistent gangrene and 2 other limbs persistent pain. The mean fol-
low-up duration was 34 months (range 1-94 months). During follow-
up, re-PTA was performed in 7 limbs (6%), surgery in 44 limbs (37%), 
major amputation in 6 limbs (5%), and minor amputation in 41 (35%).
Among 82 limbs with initial technical success, primary patency was 
70.7% at 1 year and 2 years, and the limb salvage rate was 97.6% at 
1 year and 2 years (Table 2). There were no significant differences in 
terms of 2 year primary patency (70% vs. 63%, p=0.744) and 2 year 
limb salvage (100% vs. 95%, p=1.000) regardless of the presence or 
absence of stent implantation. Moreover, there were no significant dif-
ferences in terms of 2 year primary patency (82% vs. 62%, p=0.322) 
and 2 year limb salvage (100% vs. 95%, p=1.000) regardless of the 
presence or absence of subintimal angioplasty. Kaplan-Meier analy-
sis was used to obtain primary patency (Fig. 1A) and limb salvage rates 
(Fig. 1B) during 2 year follow-up.
Overall survival was 86.1% at 1 year and 75.2% at 2 years (Table 2). 
The most common cause of death was acute myocardial infarction 
(n=10) and renal insufficiency (n=10). There was no significant differ-
ence in terms of 2 year survival (60% vs. 78%, p=0.243) irrespective 
of the presence or absence of stent implantation. Furthermore, there 
was no significant difference in terms of 2 year survival (55% vs 79%, 
p=0.126) irrespective of the presence or absence of subintimal angio-
plasty. Kaplan-Meier analysis was used to calculate survival during the 
2 year follow-up period (Fig. 2).
Univariate analysis associated with poor 2 year primary patency
Univariate analysis showed that younger age (59.9±15.6 years 
vs. 69.1±10.5 years, p=0.013), less frequent Rutherford category 4 
(8% vs. 64%, p<0.001), and more frequent Rutherford category 6 
(75% vs. 17%, p<0.001) were associated with poor 2 year primary 
patency rates (Table 3).
Multivariate analysis associated with poor 2 year primary patency
Multivariate analysis showed that young age {odds ratio (OR) 0.935, 
95% confidence interval (CI) 0.883-0.990, p=0.021} and Rutherford 
category 6 at initial presentation (OR 6.996, 95% CI 1.405-34.834, 
p=0.018) were independent predictors associated with poor 2 year 
primary patency in these patients (Table 4).
Univariate analysis associated with poor 2 year survival
Univariate analysis showed that older age (69.6±6.9 years vs. 64.3 
±15.3 years, p=0.019), lower estimated glomerular filtration rate (42.2 
±33.4 mL/min/1.73 m2 vs. 58.1±32.2 mL/min/1.73 m2, p=0.037), less 
frequent Rutherford category 4 (25% vs. 50%, p=0.020), more fre-
quent Rutherford category 6 (64% vs. 31%, p=0.002), more frequent 
Fig. 1. Kaplan-Meier analysis shows primary patency (A) and limb salvage rate (B) during 2 year follow-up among patients with initial technical success. 
Primary patency at 2 years was 70.7%, and limb salvage rate at 2 years was 97.6%.
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Fig. 2. Kaplan-Meier analysis shows overall survival during 2 year follow-
up. Overall survival at 2 years was 76.3%.
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cerebrovascular accident (25% vs. 6%, p=0.007), more frequent cor-
onary artery disease (71% vs. 49%, p=0.037), more frequent combined 
intervention of ipsilateral lower extremity (68% vs. 36%, p=0.003), 
and worse primary clinical success (68% vs. 88%, p=0.021) were as-
sociated with poor 2 year survival (Table 3).
Multivariate analysis associated with poor 2 year survival
Multivariate analysis showed that a history of cerebrovascular acci-
dent (OR 5.396, 95% CI 1.792-16.254, p=0.003) was an independent 
predictor associated with poor 2 year survival in these patients (Table 4).
Discussion
The Bypass versus Angioplasty in Severe Ischemia of the Leg (BA-
SIL) trial, a multicenter, randomized controlled trial that compared 6 
month clinical outcomes after angioplasty or surgery among CLI pa-
Table 4. Multivariate analysis of independent predictors associated with poor 2 year primary patency and poor 2 year survival
OR 95% CI p
Poor 2 year primary patency
Age (years) 0.935 0.883-0.990 0.021
Male gender 1.771 0.320-9.809 0.513
Rutherford category 4* 0.205 0.029-1.451 0.112
Rutherford category 6* 6.996   1.405-34.834 0.018
Poor 2 year survival
Age 1.019 0.975-1.065 0.408
Male gender 2.512 0.725-8.700 0.146
Estimated glomerular filtration rate 0.993 0.980-1.006 0.299
Rutherford category 4* 0.365 0.082-1.616 0.184
Rutherford category 6* 1.667 0.444-6.256 0.449
Cerebrovascular accident 5.396   1.792-16.254 0.003
Coronary artery occlusive disease 2.388 0.925-6.169 0.072
Combined intervention of ipsilateral lower extremity 2.197 0.885-5.449 0.090
Primary clinical success 0.888 0.342-2.320 0.808
*Rutherford classification can be found in reference 11. CI: confidence interval, OR: odds ratio
Table 3. Univariate analysis of predictors associated with poor 2 year primary patency and poor 2 year survival
 
 
Poor 2 year primary patency
p
Yes No
Age (years) 59.9±15.6 69.1±10.5 0.013
Male gender (%) 21 (88) 45 (78) 0.373
Rutherford category 4 (%)* 2 (8) 37 (64) <0.001
Rutherford category 6 (%)* 18 (75) 10 (17) <0.001
  Poor 2 year survival
p
  Yes No
Age (years) 69.6±6.9 64.3±15.3 0.019
Male gender (%) 25 (89) 68 (76) 0.120
EGFR (mL/min/1.73 m2) 42.2±33.4 58.1±32.2 0.037
Rutherford category 4 (%)* 50 (25) 45 (50) 0.020
Rutherford category 6 (%)* 18 (64) 28 (31) 0.002
Cerebrovascular accident (%) 7 (25) 5 (6) 0.007
Coronary artery occlusive disease (%) 20 (71) 44 (49) 0.037
Combined intervention of ipsilateral lower extremity (%) 19 (68) 32 (36) 0.003
Primary clinical success (%) 19 (68) 79 (88) 0.021
Data are expressed as the mean value±SD or percentage of patients. *Rutherford classification can be found in reference 11. EGFR: estimated glomerular 
filtration rate, SD: standard deviation
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tients, did not show a significant difference with respect to amputa-
tion-free survival, all-cause mortality and quality of life during short-
term follow-up.13) However, most data about CLI included the proximal 
segments as femoral or femopopliteal segments, and few reports have 
focused on the infrapopliteal segment due to high technical failure 
rates and low patency rates. Recently, with technological advance-
ments in wires and increased clinical experience, infrapopliteal angio-
plasty has been more frequently attempted and has shown results 
comparable to surgical bypass.4)5)14)15) In meta-analyses, which com-
pared infrapopliteal angioplasty with surgical bypass, the limb salvage 
rates of the two strategies were similar,16) and our data showed favor-
able clinical outcomes after infrapopliteal angioplasty.
A relatively low technical success rate (70%) in this study may be 
attributed to a high proportion of suboptimal results (22%). Most of 
the suboptimal results involved diffuse and heavily calcified lesions, 
and had 30% to 50% of residual stenosis despite repeated balloon 
dilatation. Any supplementary intervention such as stent implanta-
tion was not performed in those lesions. Stent implantation in infr-
apopliteal arteries have been avoided due to the diffuse, complex le-
sion characteristics in the majority of CLI cases, and the risk of crushed 
stents or thromboses due to flow stasis.6)17) Recent advancements in 
coronary stenting technology now allows for the use of stent im-
plantation in more distal crural arteries. Feiring et al.14) demonstrat-
ed that stent-supported infrapopliteal angioplasty is effective, with few 
adverse events for patients with CLI or lifestyle-limiting claudication. 
Also, Siablis et al.9) demonstrated that sirolimus-eluting stents reduced 
the restenosis rate and a favorable midterm clinical outcome was ob-
tained with a significant decrease in clinically driven re-interventions 
compared with bare metal stents in suboptimal infrapopliteal angio-
plasty. It is plausible that more aggressive use of stent implantations 
might improve angiographic and clinical results. However, our study 
showed no significant improvements of clinical outcomes, including 
2 year primary patency and 2 year survival, in the stent implantation 
group. It may be explained by the small number of cases in the stent 
implantation group. Therefore, long-term follow-up data from multi-
ple centers would be needed, and the potential benefit of stent im-
plantation should be considered over the financial cost.
Although the BASIL trial13) included patients who were good can-
didates for either infra-inguinal bypass surgery or balloon angioplas-
ty, many patients with CLI are not optimal candidates for surgical by-
pass, and most likely undergo amputation for their critical limb ischemia. 
Considering that the objective of catheter-based angioplasty is also 
to lower the rate of amputations and to support wound healing by 
ameliorating distal flow,14) angioplasty can be considered a first line 
treatment option in CLI patients who otherwise are expected to un-
dergo major amputation.
In our study, 2 year overall survival was 75.2%, and the main causes 
of death were cardiovascular events, which correspond with the sig-
nificant associations between CLI and cardiovascular morbidity or 
mortality in previous reports.18-21) Therefore, in the management of CLI 
patients with poor life expectancy, the maintenance of symptom relief 
and limb salvage is more crucial than for their quality of life.4)22)23) 
Hence, infrapopliteal angioplasty is a less-invasive, safe and reproduc-
ible method, and could be a better strategy for CLI patients with co-
morbidities who are at high surgical risk.
Several limitations of our study need to be considered. First, this 
was a retrospective study from a single institution, which can create 
referral bias. Also, extrapolation of these results to most patients with 
CLI has limited validity because of the small population size. Second, 
we did not perform follow-up angiography or other modalities for 
long-term patency in asymptomatic patients. Regular follow-up 
based on ankle-brachial index or duplex scan is needed to obtain bet-
ter patency results in future prospective studies. Third, the efficacy 
of proximal PTA in cases with combined proximal and distal angio-
plasty could not be distinguished from those of distal angioplasty 
alone. Fourth, we did not analyze the relationship between outcomes 
and prescriptions such as cilostazol after the procedure because of a 
deficiency of long-term follow-up data.
In conclusion, infrapopliteal angioplasty showed favorable clinical 
outcomes in terms of primary patency and limb salvage rate, and dem-
onstrated its feasibility as a primary choice of treatment in patients 
with CLI. Although it is still a technically challenging procedure, more 
aggressive treatment with advanced devices and more clinical expe-
rience would allow us to achieve better results.
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